Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Change in Account Payables (2016 - 2025)

IGC Pharma has reported Change in Account Payables over the past 16 years, most recently at -$303000.0 for Q3 2025.

  • Quarterly Change in Account Payables fell 15050.0% to -$303000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$142000.0 through Sep 2025, down 164.55% year-over-year, with the annual reading at $106000.0 for FY2025, 56.38% down from the prior year.
  • Change in Account Payables was -$303000.0 for Q3 2025 at IGC Pharma, down from $51000.0 in the prior quarter.
  • Over five years, Change in Account Payables peaked at $142000.0 in Q2 2023 and troughed at -$303000.0 in Q3 2025.
  • The 5-year median for Change in Account Payables is $8000.0 (2022), against an average of -$19473.7.
  • The largest YoY upside for Change in Account Payables was 2650.0% in 2025 against a maximum downside of 15050.0% in 2025.
  • A 5-year view of Change in Account Payables shows it stood at -$61000.0 in 2021, then surged by 113.11% to $8000.0 in 2022, then soared by 1125.0% to $98000.0 in 2023, then crashed by 32.65% to $66000.0 in 2024, then crashed by 559.09% to -$303000.0 in 2025.
  • Per Business Quant, the three most recent readings for IGC's Change in Account Payables are -$303000.0 (Q3 2025), $51000.0 (Q2 2025), and $44000.0 (Q1 2025).